CollPlant Biotechnologies Ltd. - stock earnings
CLGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.4 million USD | 43000 USD |
| 2023Q2 | 5.8 million USD | 10.2 million USD |
| 2023Q1 | -3.9 million USD | 433000 USD |
| 2022Q4 | -3.9 million USD | 433000 USD |
| 2022Q3 | -4.1 million USD | 58000 USD |
| 2022Q2 | -4.4 million USD | 66000 USD |
| 2022Q1 | -4.0 million USD | 66000 USD |
| 2021Q4 | -3.8 million USD | 310000 USD |
| 2021Q3 | -3.1 million USD | 140000 USD |
| 2021Q2 | -3.0 million USD | 691000 USD |
| 2021Q1 | 10.1 million USD | 14.5 million USD |
| 2020Q4 | -2.9 million USD | 557000 USD |
| 2020Q3 | 703000 USD | 4.1 million USD |
| 2020Q2 | -2.0 million USD | 823000 USD |
| 2020Q1 | -4.4 million USD | 439000 USD |
| 2019Q4 | -4.4 million USD | 439000 USD |
| 2019Q3 | -3.2 million USD | 679000 USD |
| 2019Q2 | -1.2 million USD | 606000 USD |
| 2019Q1 | 1.0 million USD | 4.2 million USD |
| 2018Q4 | 1.0 million USD | 4.2 million USD |
| 2018Q3 | -1.3 million USD | 225046 USD |
| 2018Q2 | -1.5 million USD | 178504 USD |
| 2018Q1 | -2.1 million USD | 221835 USD |
| 2017Q4 | -1.7 million USD | 273909 USD |
| 2017Q3 | -1.1 million USD | 74510 USD |
| 2017Q2 | -1.7 million USD | 57630 USD |
| 2017Q1 | -1.4 million USD | 69549 USD |
| 2016Q4 | -1.7 million USD | 51407 USD |
| 2016Q3 | -1.8 million USD | 24504 USD |
| 2016Q2 | -1.7 million USD | ? USD |
| 2016Q1 | -2.0 million USD | ? USD |
| 2015Q3 | -1.1 million USD | ? USD |
| 2015Q2 | -1.0 million USD | ? USD |
| 2015Q1 | -876215 USD | ? USD |
| 2014Q3 | -728151 USD | ? USD |
| 2014Q2 | -874763 USD | ? USD |
CLGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -6.7 million USD | 10.7 million USD |
| 2022 | -16.8 million USD | 299000 USD |
| 2021 | 409000 USD | 15.6 million USD |
| 2020 | -5.8 million USD | 6.1 million USD |
| 2019 | -14.7 million USD | 2.3 million USD |
| 2018 | -6.2 million USD | 4.8 million USD |
| 2017 | -6.1 million USD | 479917 USD |
| 2016 | -7.2 million USD | 75911 USD |
| 2015 | -4.8 million USD | ? USD |
| 2014 | -3.3 million USD | ? USD |
| 2013 | -4.7 million USD | ? USD |
| 2012 | -4.6 million USD | ? USD |
CLGN
Price: $5.85
52 week price:
Earnings Per Share: -0.62 USD
P/E Ratio: -9.35
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 28000
Market Capitalization: 60.1 million